Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prurisol vs Ziagen PK and Bioequivalence Study
NCT02101216Phase 1Completed
- Sponsor
- Innovation Pharmaceuticals Inc.
- Start
- Mar 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Abacavir hydroxyacetate in psoriasis (5 arms), sponsored by Innovation Pharmaceuticals Inc. Primary endpoints: Area under the plasma concentration versus time curve, Peak plasma concentration and 1 more. Started Mar 2014; status: completed.
02
Drugs
Abacavir hydroxyacetate
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02101216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02101216.